Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.

Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, Stylianou K, Ioannou P, Xydakis D, Tzanakis I, Papadaki A, Kallivretakis N, Nikolakakis N, Perysinaki G, Gale DP, Diamantopoulos A, Goudas P, Goumenos D, Soloukides A, Boletis I, Melexopoulou C, Georgaki E, Frysira E, Komianou F, Grekas D, Paliouras C, Alivanis P, Vergoulas G, Pierides A, Daphnis E, Deltas C.

Clin Genet. 2017 Jun 20. doi: 10.1111/cge.13077. [Epub ahead of print]

PMID:
28632965
2.

Response to Commentary on "Is There an Accurate Pre-operative Criterion for Dialysis Access Artery or Vein Diameter?"

Kakkos SK, Kaplanis N, Papachristou EC, Papadoulas SI, Lampropoulos GC, Tsolakis IA, Goumenos D.

Eur J Vasc Endovasc Surg. 2017 Jun 3. pii: S1078-5884(17)30281-2. doi: 10.1016/j.ejvs.2017.04.022. [Epub ahead of print] No abstract available.

PMID:
28587801
3.

The Significance of Inflow Artery and Tourniquet Derived Cephalic Vein Diameters on Predicting Successful Use and Patency of Arteriovenous Fistulas for Haemodialysis.

Kakkos SK, Kaplanis N, Papachristou EC, Papadoulas SI, Lampropoulos GC, Tsolakis IA, Goumenos DS.

Eur J Vasc Endovasc Surg. 2017 Jun;53(6):870-878. doi: 10.1016/j.ejvs.2017.02.006. Epub 2017 Mar 18.

PMID:
28318999
4.

Cardiovascular disease: Risk factors and applicability of a risk model in a Greek cohort of renal transplant recipients.

Anastasopoulos NA, Dounousi E, Papachristou E, Pappas C, Leontaridou E, Savvidaki E, Goumenos D, Mitsis M.

World J Transplant. 2017 Feb 24;7(1):49-56. doi: 10.5500/wjt.v7.i1.49.

5.

Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.

Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Meier Y, Larroque S, Roger SD; FIND-CKD Study investigators.

BMC Nephrol. 2017 Jan 17;18(1):24. doi: 10.1186/s12882-017-0444-6.

6.

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Jha V, Arici M, Collins AJ, Garcia-Garcia G, Hemmelgarn BR, Jafar TH, Pecoits-Filho R, Sola L, Swanepoel CR, Tchokhonelidze I, Wang AY, Kasiske BL, Wheeler DC, Spasovski G; Conference Participants.

Kidney Int. 2016 Dec;90(6):1164-1174. doi: 10.1016/j.kint.2016.09.009.

7.

Renal Replacement Therapy in Patients with Heart and Kidney Failure.

Goumenos DS, Papachristou E, Papasotiriou M.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016 Nov 1;37(2-3):43-47. doi: 10.1515/prilozi-2016-0015.

PMID:
27883326
8.

Keratins are novel markers of renal epithelial cell injury.

Djudjaj S, Papasotiriou M, B├╝low RD, Wagnerova A, Lindenmeyer MT, Cohen CD, Strnad P, Goumenos DS, Floege J, Boor P.

Kidney Int. 2016 Apr;89(4):792-808. doi: 10.1016/j.kint.2015.10.015. Epub 2016 Feb 6.

PMID:
26924053
9.

A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.

Rombopoulos G, Panitti E, Varounis C, Katsinas C, Stefanidis I, Goumenos D.

Curr Med Res Opin. 2016 May;32(5):939-47. doi: 10.1185/03007995.2016.1151777. Epub 2016 Mar 9.

PMID:
26857244
10.

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia.

Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.

PMID:
26759049
11.

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.

Feehally J, Coppo R, Troyanov S, Bellur SS, Cattran D, Cook T, Roberts IS, Verhave JC, Camilla R, Vergano L, Egido J, Wiecek A, Karkoszka H, Tesar V, Maixnerova D, Ots-Rosenberg M, Quaglia M, Rollino C, Magistroni R, Cusinato S, Cravero R, Peruzzi L, Lundberg S, Gesualdo L, Cancarini G, Feriozzi S, Ferrario F; VALIGA study of ERA-EDTA Immunonephrology Working Group.

Nephron. 2016;132(1):15-24. doi: 10.1159/000441852. Epub 2015 Nov 20.

PMID:
26586175
12.

In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.

Serino G, Pesce F, Sallustio F, De Palma G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Schena FP.

Kidney Int. 2016 Mar;89(3):683-92.

PMID:
26581012
13.

T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?

Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.

Cytokine. 2015 Dec;76(2):260-9. doi: 10.1016/j.cyto.2015.08.002. Epub 2015 Aug 22.

PMID:
26307557
14.

Treatment of IgA nephropathy based on the severity of clinical and histological features.

Kalliakmani P, Komninakis D, Gerolymos M, Papasotiriou M, Savvidaki E, Goumenos DS.

Saudi J Kidney Dis Transpl. 2015 May-Jun;26(3):516-25. doi: 10.4103/1319-2442.157356.

15.

Randomized controlled trial comparing primary and staged basilic vein transposition.

Kakkos SK, Tsolakis IA, Papadoulas SI, Lampropoulos GC, Papachristou EE, Christeas NC, Goumenos D, Lazarides MK.

Front Surg. 2015 Apr 29;2:14. doi: 10.3389/fsurg.2015.00014. eCollection 2015.

16.

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R; VALIGA study of the ERA-EDTA Immunonephrology Working Group.

J Am Soc Nephrol. 2015 Sep;26(9):2248-58. doi: 10.1681/ASN.2014070697. Epub 2015 Feb 12.

17.

Evaluation of the distribution of Paclitaxel by immunohistochemistry and nuclear magnetic resonance spectroscopy after the application of a drug-eluting balloon in the porcine ureter.

Liourdi D, Kallidonis P, Kyriazis I, Tsamandas A, Karnabatidis D, Kitrou P, Spyroulias GA, Kostopoulou ON, Marousis K, Kalpaxis DL, Goumenos DS, Liatsikos E.

J Endourol. 2015 May;29(5):580-9. doi: 10.1089/end.2014.0683. Epub 2015 Jan 19.

PMID:
25441059
18.

Gastrointestinal disorders after renal transplantation.

Savvidaki E, Papachristou E, Kazakopoulos P, Papasotiriou M, Vardoulaki M, Goumenos DS.

Transplant Proc. 2014 Nov;46(9):3183-6. doi: 10.1016/j.transproceed.2014.09.155.

PMID:
25420854
19.

Parameters influencing blood erythropoietin levels of renal transplant recipients during the early post-transplantation period.

Kalantzi M, Kalliakmani P, Papachristou E, Papasotiriou M, Savvidaki E, Zavvos V, Karavias D, Goumenos DS, Vlachojannis JG.

Transplant Proc. 2014 Nov;46(9):3179-82. doi: 10.1016/j.transproceed.2014.10.035.

PMID:
25420853
20.

Outcome of transplantation in renal allograft recipients from cadaveric donors with standard and expanded criteria: a single-center experience.

Papachristou E, Provatopoulou S, Savvidaki E, Kaplanis N, Kalliakmani P, Papasotiriou M, Fyssa L, Tsamantas A, Fokaefs E, Marangos M, Mira N, Maroulis I, Karavias D, Goumenos DS, Vlachogajannis J.

Transplant Proc. 2014 Nov;46(9):3172-4. doi: 10.1016/j.transproceed.2014.10.030.

PMID:
25420851

Supplemental Content

Loading ...
Support Center